Decibel Preliminary Q4 Revenue Grows >38% Sequentially, What About Adjusted EBITDA?

Decibel Cannabis Company Inc. DBCCF DB, provided preliminary unaudited Q4 2022 results, with record net revenue of $25.25 – $26.25 million, a more than 38% growth compared to Q3 2022.

Highlights

  • Q4 2022 record adjusted EBITDA of $6.25 – $7.25 million, a more than 47% growth from Q3 2022.

  • Achieved <3.0x debt to trailing twelve-month adjusted EBITDA

  • Targeting 2023 net revenue year-over-year growth of >35%

Management Commentary

“We remained focused on developing consumer loyalty and category expansion supported through refinement of differentiation within our products. By creating demand, it led to an abundance of attractive investment opportunities by way of automation and supply chain optimization, leading to record level gross margin in the back half of the year. Through these steps, we've grown Decibel's top and bottom line substantially, capping off the year with record level results. We are steadfast in our strategic plan that has driven our recent success, while remaining nimble to navigate a highly dynamic Canadian marketplace and ever-growing international landscape.

We plan to grow our position to become a market leader in Canada through organic growth centered around a pipeline of new, unique, and innovative products, and a strong revenue generation engine to grow distribution. Growing our footprint and recognition in Canada will in turn create a foundation to expand our brands internationally, bringing quality and choice to consumers abroad.

With demand in place, Decibel has invested aggressively to expand its margins and drive free cash flow, with a pipeline of high return on capital opportunities still in place. This year, we are increasing our focus on improving operating cash conversion with the streamlining of operations, a continued transition towards automation, and improving our balance sheet. We think this is critical given the current challenges present in the industry, and positions Decibel to further reinvest in its business and reinforce its ability to outcompete,” the company stated.

Benzinga's Cannabis Capital Conference Is Back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Photo: Benzinga edit with photo by Kindel Media on Pexels

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketspremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.